Intra-Cellular Therapies, Inc. (ITCI)
NASDAQ: ITCI · Real-Time Price · USD
85.36
-0.29 (-0.33%)
Nov 21, 2024, 1:42 PM EST - Market open
Intra-Cellular Therapies Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 9,017 | 6,893 | 5,012 | 4,264 | 2,549 | 1,896 | |
| Market Cap Growth | 54.47% | 37.53% | 17.54% | 67.27% | 34.44% | 204.17% | |
| Enterprise Value | 8,090 | 6,417 | 4,409 | 3,813 | 1,856 | 1,663 | |
| Last Close Price | 85.64 | 71.62 | 52.92 | 52.34 | 31.80 | 34.31 | |
| PS Ratio | 14.05 | 14.84 | 20.02 | 50.88 | 111.73 | 31280.51 | |
| PB Ratio | 7.93 | 11.65 | 7.64 | 10.20 | 3.88 | 9.72 | |
| P/TBV Ratio | 6.75 | 11.65 | 7.64 | 10.20 | 3.88 | 9.72 | |
| EV/Sales Ratio | 13.18 | 13.82 | 17.62 | 45.50 | 81.37 | 27438.48 | |
| Debt / Equity Ratio | 0.02 | 0.03 | 0.03 | 0.06 | 0.04 | 0.12 | |
| Asset Turnover | 0.60 | 0.63 | 0.40 | 0.14 | 0.05 | 0.00 | |
| Inventory Turnover | 7.93 | 12.03 | 9.74 | 12.91 | - | - | |
| Quick Ratio | 6.94 | 4.95 | 8.01 | 8.11 | 18.13 | 6.18 | |
| Current Ratio | 7.66 | 5.41 | 8.87 | 8.76 | 18.75 | 6.36 | |
| Return on Equity (ROE) | -9.90% | -22.39% | -47.72% | -52.87% | -53.30% | -57.62% | |
| Return on Assets (ROA) | -7.44% | -13.43% | -26.47% | -29.58% | -29.84% | -31.64% | |
| Return on Capital (ROIC) | -8.54% | -15.51% | -29.44% | -31.62% | -31.97% | -35.93% | |
| Earnings Yield | -0.96% | -2.03% | -5.11% | -6.66% | -8.91% | -7.79% | |
| FCF Yield | -0.70% | -1.81% | -5.41% | -6.09% | -9.04% | -6.79% | |
| Buyback Yield / Dilution | -5.42% | -1.95% | -15.74% | -15.47% | -27.50% | -0.87% | |
| Total Shareholder Return | -5.42% | -1.95% | -15.74% | -15.47% | -27.50% | -0.87% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.